PillRx only · Solution · Ophthalmic
Latanoprost
Latanoprost
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers5 labelers
Packages6
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.497
Latest avg · Jun 17, 2026
-11%
Since Dec 17, 2025
5
Active US suppliers
50%
Top-2 supplier share*
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sandoz Inc | unknown | 2 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.